Skip to main content
TOPRA
Toggle search
Keyword search
Toggle navigation
Keyword search
BECOME A MEMBER
CONTACT US
Sign in
About
Toggle
Our mission and values
Our history
Governance
Who's who
Contact us
Find us
Partnerships and Affiliations
TOPRA Strategic Plan 2020–2025
What is Regulatory Affairs?
Membership & Communities
Toggle
Member updates
Membership
Communities
Volunteering
Become a Fellow
Diversity & Inclusion
Board elections
Professional Development
Toggle
Career progression
All courses & events
Training
Conferences & networking
Qualifications
Apprenticeship
Bursaries
Professional registration
CPD and lifelong learning
Innovation Summit
TOPRA Summit
Regulatory Careers Live
TOPRA Jobs
Degree accreditation
Symposium
Publications & Resources
Toggle
News & insights
Regulatory Rapporteur
Members-only newsletters
TOPRA Engage+ App
TOPRA Connect newsletter
Medical device resources
Reg Intelligence Knowledge Hub
Sustainability
Wall Planner
Glossary of RA terms
Commercial Services
Toggle
Advertising opportunities
Exhibition opportunities
Hire our meeting rooms
Sponsorship opportunities
Services directory
TOPRA Jobs
Awards
About TOPRA
Professional development
My TOPRA
TOPRA shop
Membership & communities
TOPRA services
Sponsored: The early development of ATMPs
FREE SPONSORED WEBINAR - The early development of ATMPs: how to successfully bring your product from non-clinical to clinical trials.
Date:
16 November 2022
Time:
15:00 - 16.00 BST (GMT+1)
Advanced therapy medicinal products (ATMPs) are innovative therapies that encompass gene therapy, somatic cell therapy, and tissue-engineered products. These therapies are expected to bring important health benefits in diseases with a high unmet medical need.
This webinar will navigate through the development of ATMPs, e.g. what the differences are in non-clinical (in vitro/in vivo animal) development and the transfer to early clinical trials, compared to other medicinal products. The same `drug development` principles as for other drugs still apply for ATMPs, but with some interesting twists and a higher need for a `tailored` approach.
Learning Objectives:
Learn how set-up a non-clinical development plan for your ATMP product.
Explore how to ensure patient safety up to the early clinical phase, from a non-clinical and early clinical perspective.
Successfully transition your ATMP from non-clinical stage to First-in-Human (FIH)
Audience
This webinar will be suitable for professionals at all levels involved in development of ATMPs.
Speakers
Arthur Noach is Non-Clinical Expert/ Senior Consultant at Venn Life Sciences ED. He holds a degree in Pharmacy (PharmD) (Leiden and Utrecht University, The Netherlands) and a PhD in Pharmacology (Leiden University, The Netherlands) with majors in Toxicology and Pharmacokinetics. He is consulting to biotech as well as small and large pharma companies for over 23 years.
Tom Habraken Clinical Expert/ Consultant Clinical PK at Venn Life Sciences ED. He holds a degree in Drug Innovation (MSc) (Utrecht University, The Netherlands) with a focus on Pharmacokinetics. He is consulting to biotech as well as small and large pharma companies for 3 years, for a wide range of products, including ATMPs.
This webinar is sponsored by hvivo.
Disclaimer
Whilst TOPRA is running this webinar for hvivo, this is not an endorsement of hvivo, hvivo's affiliates, employees or its products and services. TOPRA is also not responsible for the content or views expressed during the webinar.
When
18/10/2022 15:00 - 16:00
Where
ONLINE
Registration is closed.
My registration status:
Not registered
Your company name
Your VAT country
Your VAT number
NOTE
Important instructions before booking -
If your company name or VAT number does not appear here or you would like to be invoiced using a different VAT number, please email
finance@topra.org
Register now
Username
Required
Password
Required
Keep me signed in
Forgot username?
|
Forgot password?
Create an account
Share this page
Share on Facebook
Share on Twitter
Share on LinkedIn
Email
More options
Bookmarks
Google+
MySpace
Reddit
StumbleUpon
Tumblr
Yammer
Previous
Next
Previous
Next
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##